Display options
Cite
Arimany-Nardi C, Minuesa G, Keller T, et al. Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions. Front Pharmacol. 2016;7:175doi: 10.3389/fphar.2016.00175.
Arimany-Nardi, C., Minuesa, G., Keller, T., Erkizia, I., Koepsell, H., Martinez-Picado, J., & Pastor-Anglada, M. (2016). Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions. Frontiers in pharmacology, 7175. https://doi.org/10.3389/fphar.2016.00175
Arimany-Nardi, Cristina, et al. "Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions." Frontiers in pharmacology vol. 7 (2016): 175. doi: https://doi.org/10.3389/fphar.2016.00175
Arimany-Nardi C, Minuesa G, Keller T, Erkizia I, Koepsell H, Martinez-Picado J, Pastor-Anglada M. Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions. Front Pharmacol. 2016 Jun 24;7:175. doi: 10.3389/fphar.2016.00175. eCollection 2016. PMID: 27445813; PMCID: PMC4919327.
Copy Download .nbib Format: NLM
Share it on

Front Pharmacol. 2016 Jun 24;7:175. doi: 10.3389/fphar.2016.00175. eCollection 2016.

Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions.

Frontiers in pharmacology

Cristina Arimany-Nardi, Gerard Minuesa, Thorsten Keller, Itziar Erkizia, Hermann Koepsell, Javier Martinez-Picado, Marçal Pastor-Anglada

Affiliations

  1. Molecular Pharmacology and Experimental Therapeutics, Department of Biochemistry and Molecular Biology, Institute of Biomedicine, University of BarcelonaBarcelona, Spain; Oncology Program, National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBER EHD), Instituto de Salud Carlos IIIMadrid, Spain.
  2. AIDS Research Institute IrsiCaixa, Institut d'Investigació en Cièncias de la Salut Germans Trias i Pujol, Universitat Autònoma de Barcelona Badalona, Spain.
  3. Department of Pharmacology, School of Medicine, University of Würzburg Würzburg, Germany.
  4. Department of Pharmacology, School of Medicine, University of WürzburgWürzburg, Germany; Department of Molecular Plant Physiology and Biophysics, Julius-von-Sachs-Institute, University of WürzburgWürzburg, Germany.
  5. AIDS Research Institute IrsiCaixa, Institut d'Investigació en Cièncias de la Salut Germans Trias i Pujol, Universitat Autònoma de BarcelonaBadalona, Spain; Universitat de Vic - Universitat Central de CatalunyaVic, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA)Barcelona, Spain.
  6. Molecular Pharmacology and Experimental Therapeutics, Department of Biochemistry and Molecular Biology, Institute of Biomedicine, University of BarcelonaBarcelona, Spain; Oncology Program, National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBER EHD), Instituto de Salud Carlos IIIMadrid, Spain; Institut de Recerca Pediàtrica Hospital Sant Joan de DéuBarcelona, Spain.

PMID: 27445813 PMCID: PMC4919327 DOI: 10.3389/fphar.2016.00175

Abstract

Lamivudine (3TC), a drug used in the treatment of HIV infection, needs to cross the plasma membrane to exert its therapeutic action. Human Organic cation transporter 1 (hOCT1), encoded by the SLC22A1 gene, is the transporter responsible for its uptake into target cells. As SLC22A1 is a highly polymorphic gene, the aim of this study was to determine how SNPs in the OCT1-encoding gene affected 3TC internalization and its interaction with other co-administered drugs. HEK293 cells stably transfected with either the wild type form or the polymorphic variants of hOCT1 were used to perform kinetic and drug-drug interaction studies. Protein co-immunoprecipitation was used to assess the impact of selected polymorphic cysteines on the oligomerization of the transporter. Results showed that 3TC transport efficiency was reduced in all polymorphic variants tested (R61C, C88R, S189L, M420del, and G465R). This was not caused by lack of oligomerization in case of variants located at the transporter extracellular loop (R61C and C88R). Drug-drug interaction measurements showed that co-administered drugs [abacavir (ABC), zidovudine (AZT), emtricitabine (FTC), tenofovir diproxil fumarate (TDF), efavirenz (EFV) and raltegravir (RAL)], differently inhibited 3TC uptake depending upon the polymorphic variant analyzed. These data highlight the need for accurate analysis of drug transporter polymorphic variants of clinical relevance, because polymorphisms can impact on substrate (3TC) translocation but even more importantly they can differentially affect drug-drug interactions at the transporter level.

Keywords: HIV infection; hOCT1; lamivudine; pharmacogenetics; therapy

References

  1. DNA Cell Biol. 1997 Jul;16(7):871-81 - PubMed
  2. Clin Pharmacol Ther. 2009 Sep;86(3):299-306 - PubMed
  3. Handb Exp Pharmacol. 2011;(201):105-67 - PubMed
  4. Hepatology. 2013 Sep;58(3):1065-73 - PubMed
  5. J Biol Chem. 2011 Oct 28;286(43):37874-86 - PubMed
  6. Pharmacogenomics J. 2015 Dec;15(6):473-87 - PubMed
  7. Pharmacogenomics J. 2015 Aug;15(4):363-71 - PubMed
  8. Pharm Res. 2007 Jul;24(7):1227-51 - PubMed
  9. Nat Med. 2012 Feb 19;18(3):446-51 - PubMed
  10. Mol Pharmacol. 2013 Aug;84(2):182-9 - PubMed
  11. Hepatology. 2009 Oct;50(4):1227-40 - PubMed
  12. J Clin Invest. 2007 May;117(5):1422-31 - PubMed
  13. Pharmacogenomics J. 2011 Dec;11(6):400-11 - PubMed
  14. Biopharm Drug Dispos. 2012 Apr;33(3):170-8 - PubMed
  15. Infection. 2013 Apr;41(2):379-85 - PubMed
  16. Clin Pharmacol Ther. 2008 Feb;83(2):273-80 - PubMed
  17. FASEB J. 2012 Mar;26(3):976-86 - PubMed
  18. Clin Pharmacokinet. 1999 Jan;36(1):41-66 - PubMed
  19. Proc Natl Acad Sci U S A. 2003 May 13;100(10):5902-7 - PubMed
  20. Pharmacogenetics. 2002 Nov;12(8):591-5 - PubMed
  21. J Pharmacol Exp Ther. 2008 Feb;324(2):558-67 - PubMed
  22. J Pharmacol Exp Ther. 2009 Apr;329(1):252-61 - PubMed
  23. Mol Pharm. 2012 Jun 4;9(6):1693-704 - PubMed
  24. Drug Metab Dispos. 2008 Aug;36(8):1616-23 - PubMed

Publication Types